Complications of Pregnancy/Headache




© Springer International Publishing Switzerland 2017
Carolyn Bernstein and Tamara C. Takoudes (eds.)Medical Problems During Pregnancy10.1007/978-3-319-39328-5_2


Medical Complications of Pregnancy/Headache



Carolyn Bernstein 


(1)
Department of Neurology, Brigham and Womens Hospital, Boston, MA, USA

 



 

Carolyn Bernstein



Keywords
MigraineVenous thrombosisHeadacheAuraIdiopathic intracranial hypertensionArteriovenous malformationBrain tumor


Clinicians are understandably concerned when a pregnant patient describes headache. Onset, duration, positional worsening, and accompanying features all figure into understanding the pathophysiology and making a determination for proper evaluation and subsequent treatment. Most concerning is the patient who has never had headache prior to the pregnancy who is now presenting with new and severe pain. Three illustrative actual cases will highlight salient features.

Neurologists approach a chief complaint of headache with meticulous wariness. The majority of headaches are benign, meaning that the pain is primary (without concerning secondary cause). Examples of primary headache include migraine and tension-type headache. Migraine is very common, affecting 18 % of American women. The condition is most common in women of childbearing age; migraine prevalence decreases postmenopause. It is genetic, with the predisposition running in families, and, often, patients can recall an elderly family member who had “sick headache” even if not formally diagnosed with migraine. The International Headache Society (IHS) has specific guidelines for making the diagnosis. A person must have at least five attacks lasting between 4 and 72 h of moderate to severe intensity, unilateral and throbbing in nature, accompanied by nausea or vomiting, or light and sound sensitivity. Patients often feel that if the headache is not excruciating, then it cannot be a migraine. An accurate diagnosis prior to pregnancy is helpful; migraine incidence decreases substantially during pregnancy. If a migraine patient who has been stable throughout the pregnancy describes a worsening in the third trimester, this should prompt a careful evaluation.

Tension-type headache, formally called “muscle contraction headache” or “hatband headache,” is quite common. IHS criteria define this phenotype as a headache, which is bilateral, squeezing, or pressing in description, mild to moderate intensity, with few other associated features. Fatigue, muscle spasm, and stress can certainly trigger a tension-type headache, and often rest alone is enough to let the pain improve. Patients are usually able to complete their regular tasks despite a tension-type headache; it is worth recognizing this description, as these headaches are far less worrisome.

A patient describing a new and different headache is concerning. Headaches that are explosive in onset may represent CNS bleeding, such as aneurysm rupture. These are the “thunderclap” headaches. If a patient describes an acute onset with any sort of change in consciousness, she should be directed to emergency evaluation at once. Headaches that are worse with bending over, positional, accompanied by focal numbness or weakness, vertigo, or diplopia (double vision) are also worrisome and should be promptly evaluated. “New and different” or “first or worst” are useful monikers.

Headache evaluation includes a detailed history with documentation of the start and frequency of the headaches, as well as any specific characteristics. Neurologic exam is essential; any focality or sign of increased intracranial pressure such as abnormal funduscopic exam requires further evaluation. Any concern for preeclampsia would of course prompt immediate evaluation.

During pregnancy, radiation should be avoided if possible especially during the first trimester although exposure to the fetus from a non-contrast head CT is less than 0.01 rad. The American College of Radiology states that pregnant women can undergo MRI imaging at any stage of pregnancy; it is a risk-benefit decision and should be performed only if absolutely necessary. There is very little data about gadolinium contrast safety, and contrast should be avoided if possible. MRI, MR angiogram, and MR venogram can all be performed without contrast. The neurologist and obstetrician should consult and make appropriate recommendations, explaining potential fetal risk, to the mother. If the evaluating neurologist has concern for a secondary cause of headache, it may well be necessary to image.

Once the patient has been diagnosed, treatment discussion should also be a joint process. Minimizing medication is important whenever possible, but if the mother’s disability from even a nonconcerning headache diagnosis such as migraine is great enough to impair her ability to function, medication may be necessary. Depending on the level of fetal development, there may be more options. Some of these will be discussed below. Acupuncture, biofeedback, and cognitive behavioral therapy are options for patients; some of these treatments are covered by health insurance. Massage may also help if the headache is considered secondary to muscle train; dry-needled trigger point injections can be an option as well.


Case One


Susan is a 31-year-old right-handed woman with a 10-year history of migraine with aura. She has two to three episodes each month of scintillating scotoma (visual obscuration surrounded by a glowing border), which last between 10 and 30 min. After the aura resolves, she develops a unilateral pain in one temple, right more commonly than left, which throbs and pulsates. She is photophobic and phonophobic and often becomes so nauseated that she will vomit. Untreated, the headache lasts about 6 h and may be so severe at times that she is unable to work or focus and must lie quietly in the dark. She has successfully treated with a combination of 10 mg of rizatriptan plus 500 mg of naproxen, which now will abort the entire process within an hour, and if she treats at the onset of the aura, the medication may entirely prevent the subsequent headache. She has been meticulously evaluated and her normal neurologic examination and the intermittent nature of her episodes have affirmed a clinical diagnosis of migraine with aura, meeting ICHD 3-beta diagnostic criteria.

Susan feels that her migraines became more severe when she completed her graduate studies and began working full time as a teacher. She manages her triggers carefully, focusing on regular sleep and hydration, but she credits topiramate, an antiepileptic medication that is also approved by the FDA for migraine prevention, as the most significant intervention in her migraine treatment. Prior to daily medication treatment, Susan experienced at least six migraines each month, and she found the episodes difficult to manage even with abortive medications. She worked diligently with her neurologist to tailor an individual plan for treatment and prevention and has felt well with a low disability scale score (MIDAS) for the past 3 years. Of note is that migraines are associated with an increased risk of preeclampsia.

Six months prior to becoming pregnant, Susan had her Mirena IUD removed and began taking prenatal vitamins; she had tapered off of the topiramate over 3 weeks. She was delighted to become pregnant after 3 months; her migraines have been quiet during the first trimester. Topiramate is class D during pregnancy; its use has been associated with increased risk of cleft lip/palate in a developing fetus [1]. The FDA reclassified this medication in 2011. This is the only malformation associated with topiramate; risk may be secondary to epilepsy as opposed to medication specifically. To date, there is no known association of migraine with fetal malformation. Statistically, migraine decreases with each successive trimester. The Norwegian MIGRA study was reported in 2011 [2]. Participants kept diaries throughout their pregnancies and reported a successive decrease in both the frequency and duration of headaches including self-reported migraine. When migraine patients, both with and without aura, are considering pregnancy, it is important to plan carefully and to minimize medications as much as possible, in particular those with known teratogenic effects [3].

Susan’s migraines increased slightly in frequency after her first trimester. She had four to five events per month, each of which was treated with acetaminophen. New data does not show increase in major congenital malformations in women who used triptans during pregnancy compared to healthy non-triptan using controls. A formulation of acetaminophen/caffeine/butalbital is sometimes offered to pregnant women as a migraine abortive. This medication is also class C. Obstetricians sometimes favor its use as it has been available for many years, and there are few adverse outcomes associated. However, both the caffeine and the barbiturate components may affect a developing fetus, and the combination of the three medications can cause or contribute to medication overuse headache. Susan’s obstetrician preferred that she avoid her prepregnancy abortive of rizatriptan and naproxen (note: there is more data for sumatriptan as it was the initial available molecule in this class) [4]. Susan had begun a course of cognitive behavioral therapy prior to her pregnancy and was often able to use meditation to decrease the pain when she did suffer a migraine. She stabilized with respect to the migraines and had a healthy baby girl at 37 weeks of gestation.

Ten days after the delivery, Susan developed a headache that was identical in description to her typical migraine although the pain was continuous. It was unilateral and throbbing. She had mild nausea and both photophobia and phonophobia. Both NSAIDs and some triptans are considered compatible with breast-feeding. Susan took 400 mg of ibuprofen with 100 mg of sumatriptan and the pain decreased slightly but persisted over the next 3 days. After 72 h, a continuous migraine is classified as status migrainosus. Susan presented to her neurologist and a thorough neurologic exam was normal. She was given an injection of ketorolac and felt better within 30 min.

The subsequent day, the pain returned. She had an MRI/MRV and was found to have a sagittal sinus thrombosis. Susan was admitted to the hospital and after a hypercoagulable screen was drawn, she was started on IV heparin and oral warfarin. Although warfarin is considered safe during breast-feeding, Susan felt more comfortable switching her daughter to formula, and a lactation consultant helped with the transition. Her hypercoagulable screen was negative, and the thrombosis was considered secondary to peripartum hypercoagulability. After 6 months of treatment with warfarin, Susan was able to stop the medication and has done well for 3 years. She was reimaged and the clot had canalized. Susan was counseled that she could have another CVT during a subsequent pregnancy and has chosen to limit her family to one child.

Pregnancy and puerperium are risk for CVT due to prothrombotic state independent of other factors such as infection and cesarean section [5]. Risk increases during the third trimester in particular. One study estimates 12 cases per 100,000 deliveries. During the pregnancy, patients may be treated with low molecular weight heparin; after delivery, the mother may be switched to warfarin [6].

This case illustrates a variation in the normal course of migraine during pregnancy and then a prolonged headache, which raised suspicion for other diagnostic possibilities. Understanding the typical course of migraine in pregnant patients, familiarity with safe treatment options including CBT, and quick recognition of a concerning change in headache duration were instrumental in managing this patient through a worrisome presentation* [7, 8].


Case Two


Barbara is a 28-year-old left-handed teacher with no neurologic history. She is pregnant with her second child and has had an uncomplicated course. Her first pregnancy was significant for hyperemesis gravidarum for which she was admitted to the hospital during the first trimester for intravenous fluids. At 35 weeks gestation, she develops headache, which is global and nonlocalized. She describes pressing throbbing sensation with brief bursts of more severe pain. Her vision is normal and she denies any focal numbness or weakness. The pain responds to acetaminophen. An intermittent headache persists over the next 2 weeks and she notes fatigue and mild nausea. Barbara goes into spontaneous labor at 37 weeks. Five hours into what has been an uncomplicated labor, she has a generalized convulsion, which lasts 60 s. She is treated with intravenous magnesium and lorazepam and a cesarean section is performed. The baby girl has Apgar scores of nine and nine; Barbara does well after the delivery. She has no further seizure activity.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Nov 8, 2017 | Posted by in OBSTETRICS | Comments Off on Complications of Pregnancy/Headache

Full access? Get Clinical Tree

Get Clinical Tree app for offline access